Scarica l'app Stockscreener
1.82
3.19%
-0.06
Propanc Biopharma Inc Borsa (PPCB) Ultime notizie
Propanc signs MOU with Avance Clinical for phase 1b trial - Investing.com
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd - The Manila Times
Propanc lines up Avance Clinical for first human PRP cancer trial - Stock Titan
Propanc Biopharma PPCB Surges After $5M Buyback Move - timothysykes.com
Propanc Biopharma launches $5M share repurchase program - MSN
PPCB Should I Buy - Intellectia AI
PPCB Stock Rockets As Buyback Fuels Biotech Momentum - StocksToTrade
Trending Industry Today: Propanc Biopharma Leads Gains In Crypto Treasury Stocks - Moomoo
Propanc Biopharma | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Propanc Biopharma initiates $500,000 share buyback program - Investing.com
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program - The Manila Times
Propanc Biopharma begins $500,000 stock buyback over 30 days - Stock Titan
Enterprise value to revenue forward of Propanc Biopharma, Inc. – NASDAQ:PPCB - TradingView
Number of shareholders of Propanc Biopharma, Inc. – NASDAQ:PPCB - TradingView
Propanc Biopharma | CORRESP: CORRESP - Moomoo
PPCB stock surges over 200% just days after implementing reverse share split – what’s driving today’s smashing rally? - MSN
PROPANC BIOPHARMA INC (PPCB) Stock Chart - ChartMill
Propanc Biopharma Ord Shs (PPCB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Propanc CEO tours European manufacturing facility for drug production - Investing.com UK
Propanc CEO visits European manufacturer ahead of drug production plan - TipRanks
Propanc CEO tours European manufacturing facility for drug production By Investing.com - Investing.com South Africa
Propanc CEO visits European manufacturing facility for PRP production - Investing.com
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study - GlobeNewswire
Nasdaq most active stocks: - MSN
Propanc Biopharma (PPCB) Surges 80% as Trading Volume SpikesVOLD Alert - newsline.com
Top Midday Gainers - Moomoo
Trending Industry Today: Propanc Biopharma Leads Gains In ETH-Holding Companies Stocks - Moomoo
Top movers analysis one hour before the close of the markets on 2026-06-11: top gainers and losers in today's session. - ChartMill
These stocks are the most active in today's session - ChartMill
PPCB Stock Surges Over 200% Just Days After Implementing Reverse Share Split – What’s Driving Today’s Smashing Rally? - Asianet Newsable
Clinical-Stage Biotech Rockets 308% After $5M Buyback and Phase 1 Cancer-Trial Path - The Globe and Mail
Propanc Biopharma authorizes $5M share buyback program; shares surge - MSN
Propanc Biopharma, Inc. authorizes a Buyback Plan. - marketscreener.com
Propanc Biopharma, Inc. announces an Equity Buyback for $5 million worth of its shares. - marketscreener.com
Propanc Biopharma rockets after announcing $5M share repurchase program - Quiver Quantitative
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React - TechStock²
Propanc Biopharma Authorizes $5 Million Stock Buyback Program; Shares Jump - marketscreener.com
Trending Stocks Today | Propanc Biopharma Surges 282.95% - Moomoo
PPCB Stock Explodes As PRP Trial Plans Heat Up - StocksToTrade
PPCB Stock Pops As Propanc Biopharma Advances PRP Trials - timothysykes.com
Propanc Biopharma authorizes $5 million stock buyback program - Investing.com
Propanc Biopharma authorizes $5 million stock buyback program By Investing.com - Investing.com Australia
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program - The Manila Times
Cancer-drug developer Propanc sets aside $5M to buy its own stock - Stock Titan
Morning Market Movers: GLXG, PPCB, DSY, VSME See Big Swings - RTTNews
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain - markets.businessinsider.com
Propanc Biopharma's CEO Attends Keynote Address on Aging Science at University of Granada Event - Quiver Quantitative
How an ageing-science keynote ties into Propanc’s cancer trial - Stock Titan
Propanc Biopharma (PPCB) Surges 5.56% as Stock Tests Key Resistance at $1.80Andrews Pitchfork - dars.gov.et
PPCBPropanc Biopharma Inc Stock Price and Quote - Finviz
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):